Literature DB >> 19734283

Slackia equolifaciens sp. nov., a human intestinal bacterium capable of producing equol.

Jong-Sik Jin1,2,3, Maki Kitahara1, Mitsuo Sakamoto1, Masao Hattori2, Yoshimi Benno3.   

Abstract

An equol-producing bacterium, strain DZE(T), which was isolated from human faeces, was characterized by morphological, biochemical and molecular methods. The isolate was Gram-positive, obligately anaerobic, non-spore-forming, asaccharolytic and rod-shaped. 16S rRNA gene sequence analysis showed 92.8, 91.0, 91.1 and 90.6% similarities with Slackia faecicanis, Slackia exigua, Slackia heliotrinireducens and Slackia isoflavoniconvertens, respectively. Based on these data, we propose a novel species of the genus Slackia, Slackia equolifaciens sp. nov. The major cellular fatty acids are C14:0, C18:1omega9c and C18:1omega9c DMA (dimethyl acetal). The DNA G+C content of the strain is 60.8 mol%. The type strain of S. equolifaciens sp. nov. is DZET (=JCM 16059T =CCUG 58231T).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734283     DOI: 10.1099/ijs.0.016774-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  31 in total

Review 1.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

Review 2.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

Review 3.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

Review 4.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

Review 5.  Cardiovascular and Antiobesity Effects of Resveratrol Mediated through the Gut Microbiota.

Authors:  Julia K Bird; Daniel Raederstorff; Peter Weber; Robert E Steinert
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

Review 6.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

Review 7.  Bacterial species involved in the conversion of dietary flavonoids in the human gut.

Authors:  Annett Braune; Michael Blaut
Journal:  Gut Microbes       Date:  2016-03-10

Review 8.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

9.  Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.

Authors:  Yoshie Nagata; Yukiko Sugiyama; Fumimasa Fukuta; Akio Takayanagi; Naoya Masumori; Taiji Tsukamoto; Hiroshi Akasaka; Hirofumi Ohnishi; Shigeyuki Saitoh; Tetsuji Miura; Kaoru Moriyama; Hirokazu Tsuji; Hideyuki Akaza; Mitsuru Mori
Journal:  Int Urol Nephrol       Date:  2016-06-04       Impact factor: 2.370

Review 10.  Isoflavones and inflammatory bowel disease.

Authors:  Ze-Yu Wu; Li-Xuan Sang; Bing Chang
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.